Skip to main content

Integrative Therapies for Lung Transplantation Recipients

  • Chapter
  • First Online:
Integrative Therapies in Lung Health and Sleep

Abstract

The prevalence of integrative therapy usage after lung transplantation is high. The interest in seeking integrative therapies for better symptoms management and health maintenance is likely to grow given the overall symptom burden and psychological distress and complications after lung transplantation. However, empirical evidence regarding the effects and safety of particular integrated therapy practices in lung transplant populations is seriously lacking. Also unknown are the interactions between complementary and alternative therapies and the conventional medical therapies prescribed for lung transplantation. In this chapter, we present what little evidence exists to guide clinicians in advising lung transplant recipients regarding the safety and efficacy of integrative therapy usage. Nonetheless, the success of integrative therapies in other settings and populations demand that more attention be paid to this important area in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McCurry KR, Shearon TH, Edwards LB, Chan KM, Sweet SC, Valapour M, Yusen R, Murray S. Lung transplantation in the United States, 1998–2007. Am J Transplant. 2009;9(Part 2):942–58.

    Article  PubMed  CAS  Google Scholar 

  2. Christie JD, Edwards LB, Kucheryavaya AY, Aurora P, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report—2010. J Heart Lung Transplant. 2010;29(10):1104–18.

    Article  PubMed  Google Scholar 

  3. U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. 2009 Annual Report, Transplant Data 1999–2008. Richmond: United Network for Organ Sharing; 2006. http://optn.transplant.hrsa.gov/ar2009/. Accessed December 20, 2010.

  4. Eurotransplant International Foundation. Annual report 2009. Leiden: Eurotransplant International Foundation.

    Google Scholar 

  5. Department of Health & Human Services. Organ procurement and transplantation network: final rule. Federal Register 1999;42 CFR:56649–61.

    Google Scholar 

  6. Egan TM, Murray S, Bustami RT, et al. Development of the new lung allocations system in the United States. Am J Transplant. 2006;6:1212–27.

    Article  PubMed  CAS  Google Scholar 

  7. Organ Procurement and Transplantation Network (OPTN). Policies. Revision to policy 3.7.6.1. 2010. http://www.optn.org/PoliciesandBylaws2/policies/pdfs/policy_9.pdf. Accessed December 19, 2010.

  8. Levine GN, McCullough KP, Rodgers AM, Dickinson DM, Ashby VB, Schaubel DE. Analytical methods and database design: implications for transplant researchers. Am J Transplant. 2005;6(Part 2):1128–242.

    Google Scholar 

  9. DeVito Dabbs AJ, Song MK. Risk profile for cardiovascular morbidity and mortality after lung transplantation. Nurs Clin North Am. 2008;43:37–53.

    Article  Google Scholar 

  10. DeVito Dabbs AJ, Hoffman LA, Iacono AT, Wells CL, Grgurich W, Zullo TG, McCurry KR, dauber JH. Pattern and predictors of early rejection after lung transplantation. Am J Crit Care. 2003;12(6):497–507.

    PubMed  Google Scholar 

  11. Song MK, De Vito Dabbs AJ. Advance care planning after lung transplantation: a case of missed opportunities. Prog Transplant. 2006;16(3):222–5.

    PubMed  Google Scholar 

  12. Song MK, De Vito Dabbs A, Studer SM, Zangle SE. Course of illness after the onset of chronic rejection in lung transplant recipients. Am J Crit Care. 2008;17(3):246–53.

    PubMed  Google Scholar 

  13. Dew MA, Switzer GE, Goycoolea JM, Allen AS, DiMartini A, Kormos RL, Griffith BP. Does transplantation produce quality of life benefits? A quantitative analysis of the literature. Transplantation. 1997;64(9):1261–73.

    Article  PubMed  CAS  Google Scholar 

  14. Lanuza DM, Lefaiver CA, Farcas GA. Research on the quality of life of lung transplant candidates and recipients: an integrative review. Heart Lung. 2000;29:180.

    Article  PubMed  CAS  Google Scholar 

  15. Myaskovsky L, Dew MA, McNulty ML, Switzer GE, DiMartini AF, Kormos RL, McCurry KR. Trajectories of change in quality of life in 12-month survivors of lung or heart transplant. Am J Transplant. 2006;6(8):1939–47.

    Article  PubMed  CAS  Google Scholar 

  16. DeVito Dabbs AJ, Dew MA, Stilley CS, Manzetti J, Zullo T, McCurry KR, Kormos RL, Iacono A. Psychosocial vulnerability, physical symptoms and physical impairment after lung and heart-lung transplantation. J Heart Lung Transplant. 2003;22:1268–75.

    Article  Google Scholar 

  17. DeVito Dabbs AJ, Hoffman LA, Lacono AT, Zullo TG, Mc Curry KR, Dauber JH. Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation? Heart Lung. 2004;33(6):372–80.

    Article  Google Scholar 

  18. Cupples S, Dew MA, Grady KL, DeGeest S, Dobbels F, Lanuza D, Paris W. Report of the Psychosocial Outcomes Workgroup of the Nursing and Social Sciences Council of the International Society for Heart and Lung Transplantation: present status of research on psychosocial outcomes in cardiothoracic transplantation: review and recommendations for the field. J Heart Lung Transplant. 2006;25(6):716–25.

    Article  PubMed  Google Scholar 

  19. Krakauer H, Beiley RC, Lin MJ. Beyond survival: the burden of disease in decision making in organ transplantation. Am J Transplant. 2004;4:1555–61.

    Article  PubMed  Google Scholar 

  20. Rothman ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Patient-reported outcome: conceptual issues. Value Health. 2007;10 Suppl 2:S66–75.

    Google Scholar 

  21. Dew MA, DiMartini AF, DeVito Dabbs A, Zomak R, De Geest S, Dobbels F, Myaskovsky L, Switzer GE, Unruh M, Steel JL, Kormos RL, McCurry KR. Adherence to the medical regimen during the first two years after lung transplantation. Transplantation. 2008;85(2):193–202.

    Article  PubMed  Google Scholar 

  22. DeVito Dabbs AJ, Johnson B, Wardzinski WT, Iacono A, Studer S. Development and evaluation of the electronic version of the Questionnaire for Lung Transplant Patients (e-QLTP). Prog Transplant. 2007;17(1):29–35.

    Google Scholar 

  23. Lanuza DL, McCabe M. Care before and after lung transplant and quality of life research. AACN Clin Issues. 2001;12:186–201.

    Article  PubMed  CAS  Google Scholar 

  24. Stilley CS, Dew MA, Stukas AA, et al. Psychological symptom levels and their correlates in lung and heart-lung transplant recipients. Psychosomatics. 1999;40:503–9.

    Article  PubMed  CAS  Google Scholar 

  25. Astin JA. Why patients use alternative medicine: results of a national survey. JAMA. 1998;279(19):1548–53.

    Article  PubMed  CAS  Google Scholar 

  26. Astin JA, Pelleiter KR, Marie A, Haskell WL. Complementary and alternative medicine use among elderly persons: one year analysis of a Blue Shield Medicare supplement. Gerontol A Biol Sci Med Sci. 2000;55(1):M4–9.

    Article  CAS  Google Scholar 

  27. Barnes PM, Bloom BL, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. National Health Statistics Reports: no. 12. Hyattsville. National Center for Health Statistics; 2008.

    Google Scholar 

  28. Humpel N, Jones SC. Gaining insight into the what, why, and where of complementary and alternative medicine use by cancer patients and survivors. Eur J Cancer Care. 2006;15(4):362–8.

    Article  CAS  Google Scholar 

  29. Shen J, Andersen R, Albert PS, Wenger N, Glaspy J, Cole M, Shekelle P. Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med. 2002;2:8.

    Article  PubMed  Google Scholar 

  30. Wolsko PM, Eisenberg DM, Davis RB, Ettner SL, Phillips RS. Insurance coverage, medical conditions and visits to alternative medicine providers: results of a national survey. Arch Intern Med. 2002;162(3):281–7.

    Article  PubMed  Google Scholar 

  31. Crone CC, Wise TN. Survey of alternative medicine use among organ transplant recipients. J Transpl Coord. 1997;7:123–30.

    PubMed  CAS  Google Scholar 

  32. Matthees BJ, Anantachoti P, Kreitzer MJ, Savik K, Hertz MI, Gross CR. Use of complementary therapies, adherence, and quality of life in lung transplant recipients. Heart Lung. 2001;30(4):258–68.

    Article  PubMed  CAS  Google Scholar 

  33. Tinkerhoof L, Wagener MM, Cacciarelli T, Singh N. Alternative therapy in liver transplant recipients. Prog Transplant. 2006;16(3):226–31.

    Google Scholar 

  34. Hess S, DeGeest S, Hatler K, Dickenmann M, Denhaerynck K. Prevalence and correlates of selected alternative and complementary medicine in adult renal transplant patients. Clin Transplant. 2009;23:56–62.

    Google Scholar 

  35. Lake KD, Nolen JG, Slaker RA, Reutzel TJ, Milfred SK, Solbrack D, Hoffman FM. Over-the-counter medications in cardiac transplant recipients: guidelines for use. Ann Pharmacother. 1992;26(12):1566–75.

    PubMed  CAS  Google Scholar 

  36. Ellingson T, Wipke-Tevis D, Messina C, Livesay T. The use of over-the-counter medications by transplant recipients: a guideline. J Transpl Coord. 1999;9(1):17–24.

    PubMed  CAS  Google Scholar 

  37. Gross CR, Kreitzer MJ, Russas V. Mindfulness meditation to reduce symptoms after organ transplant: a pilot study. Altern Ther Health Med. 2004;10(3):58–66.

    PubMed  Google Scholar 

  38. Gross CR, Kreitzer MJ, Thomas W, Reilly-Spong M, Cramer-Bornemann M, Nyman JA, Frazier P, Ibrahim HN. Mindfulness-based stress reduction for solid organ transplant recipients: a randomized controlled trial. Altern Ther Health Med. 2010;16(5):30–8.

    PubMed  Google Scholar 

  39. Gross CR, Kreitzer MJ, Reilly-Spong M, Winbush NY, Schomaker EK, Thomas W. Mindfulness meditation training to reduce symptom distress in transplant patients: rationale, design, and experience with a recycled waitlist. Clin Trials. 2009;6:76–89.

    Article  PubMed  Google Scholar 

  40. Dew MA, DiMartini AF. Psychological disorders and distress after adult cardiothoracic transplantation. J Cardiovasc Nurs. 2005;20:S51–66.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Annette DeVito Dabbs PhD, RN, FAAN .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Dabbs, A.D., Song, MK., Switzer, S.D. (2012). Integrative Therapies for Lung Transplantation Recipients. In: Chlan, L., Hertz, M. (eds) Integrative Therapies in Lung Health and Sleep. Respiratory Medicine, vol 4. Humana Press. https://doi.org/10.1007/978-1-61779-579-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-579-4_8

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-578-7

  • Online ISBN: 978-1-61779-579-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics